Literature DB >> 17499511

N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors.

Anna Drabczyńska1, Christa E Müller, Janina Karolak-Wojciechowska, Britta Schumacher, Anke Schiedel, Olga Yuzlenko, Katarzyna Kieć-Kononowicz.   

Abstract

Synthesis and physicochemical properties of N-benzyl pyrimido[2,1-f]purinediones are described. These derivatives were synthesized by the cyclization of 7-chloropropylo-8-bromo-1,3-dimethyl- or 1,3-dipropyl xanthine derivatives with corresponding (un)substituted benzylamines. Dipropyl derivatives were obtained under microwave irradiation conditions either. The obtained compounds (1-20) were evaluated for their affinity to adenosine A1 and A2A receptors, selected compounds were additionally investigated for affinity to the A3 receptor subtype. The results of the radioligand binding assays to A1 and A2A adenosine receptors showed that most of the 1,3-dimethyl-9-benzylpyrimidopurinediones exhibited selective affinity to A2A receptors at micromolar or submicromolar concentrations (for example, derivative 9 with o-methoxy substituent displayed a Ki value of 0.699 microM at rat A2A receptor with more than 36-fold selectivity). Contrary to previously described arylpyrimido[2,1-f]purinediones dipropyl derivatives (compounds 15-20) showed affinity to both kinds of receptors increased, however A1 affinity increased to a larger extent, with the result that A2A selectivity was abolished. The best adenosine A1 receptor ligand was m-chlorobenzyl derivative 18 (Ki=0.089 microM and 5-fold A1 selectivity). Structure-activity relationships were discussed with the analysis of lipophilic and spatial properties of the investigated compounds. Pharmacophore model of adenosine A1 receptor antagonist was adopted for this purpose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499511     DOI: 10.1016/j.bmc.2007.04.018

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

Review 1.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

2.  Synthesis of BODIPY derivatives substituted with various bioconjugatable linker groups: a construction kit for fluorescent labeling of receptor ligands.

Authors:  Fabian Heisig; Sabrina Gollos; Sven J Freudenthal; Ali El-Tayeb; Jamshed Iqbal; Christa E Müller
Journal:  J Fluoresc       Date:  2013-09-20       Impact factor: 2.217

3.  Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones.

Authors:  Anna Drabczyńska; Tadeusz Karcz; Ewa Szymańska; Meryem Köse; Christa E Müller; Minka Paskaleva; Janina Karolak-Wojciechowska; Jadwiga Handzlik; Olga Yuzlenko; Katarzyna Kieć-Kononowicz
Journal:  Purinergic Signal       Date:  2013-04-02       Impact factor: 3.765

4.  Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties.

Authors:  Michał Załuski; Katarzyna Stanuch; Tadeusz Karcz; Sonja Hinz; Gniewomir Latacz; Ewa Szymańska; Jakub Schabikowski; Agata Doroż-Płonka; Jadwiga Handzlik; Anna Drabczyńska; Christa E Müller; Katarzyna Kieć-Kononowicz
Journal:  Medchemcomm       Date:  2018-05-14       Impact factor: 3.597

5.  Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity.

Authors:  Pierre Koch; Andreas Brunschweiger; Vigneshwaran Namasivayam; Stefan Ullrich; Annalisa Maruca; Beatrice Lazzaretto; Petra Küppers; Sonja Hinz; Jörg Hockemeyer; Michael Wiese; Jag Heer; Stefano Alcaro; Katarzyna Kiec-Kononowicz; Christa E Müller
Journal:  Front Chem       Date:  2018-06-26       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.